Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Hamostaseologie|August 18, 2004
[Monitoring of tienopyridines or glycoprotein IIb/IIIa-receptor antagonists: simple platelet function tests]W-M Halbmayer
Thrombosis Research|September 28, 1999
Rational, high quality laboratory monitoring before, during, and after infusion of prothrombin complex concentratesW M Halbmayer
Wiener Medizinische Wochenschrift (1946)|January 1, 1993
[Prothrombin fragment 1+2 (F1+2), thrombin-antithrombin III complex(TAT) and thrombophilia parameters in orally anticoagulated patients with inferior vena cava filters]W M Halbmayer, A Haushofer, E Toth
Wiener Medizinische Wochenschrift (1946)|January 1, 1991
[Automation in the modern coagulation laboratory. Exemplified by the integration of the Microanalyser ACL 300]A Haushofer, W M Halbmayer, M Fischer
Wiener Klinische Wochenschrift|January 1, 1995
[External quality assurance: a significant--and 25-year-old--element of quality management in the medical diagnostic laboratory]W M Halbmayer, E Legenstein, E Kaiser
Thrombosis Research|May 1, 1990
Zinc modulates thrombin adsorption to fibrinP Hopmeier, M Halbmayer, M Fischer, et al.
Wiener Medizinische Wochenschrift (1946)|January 1, 1993
[Preoperative monitoring of blood coagulation in urologic operations: diagnosis of familial factor XI deficiency within the scope of preoperative blood coagulation studies]A Haushofer, W M Halbmayer, E Toth, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 1, 1994
The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjectsW M Halbmayer, A Haushofer, R Schön, et al.
Medizinische Klinik (Munich, Germany : 1983)|March 15, 1992
[Functional protein S in 77 patients treated with anticoagulants and in 32 probands with normal coagulation parameters]W M Halbmayer, C Feichtinger, K Rubi, et al.
Angiology|April 1, 1995
Quality assurance of high-dose i.v. heparin treatment exemplified by patients implanted with coronary Palmaz-Schatz stentsA Haushofer, W M Halbmayer, H Prachar, et al.
Pageof 4